Decoding 10 Analyst Evaluations For Genmab
Decoding 10 Analyst Evaluations For Genmab
对genmab进行10位分析师评估的解读
The analysis of...10 analysts have expressed a variety of opinions on Genmab (NASDAQ:GMAB) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去的一个季度中，10位分析师对Genmab（纳斯达克股票代码：GMAB）表达了各种观点，从看涨到看跌，提出了各种各样的观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts have recently evaluated Genmab and provided 12-month price targets. The average target is $50.0, accompanied by a high estimate of $53.00 and a low estimate of $47.00. Witnessing a positive shift, the current average has risen by 0.81% from the previous average price target of $49.60.
分析师最近对Genmab进行了评估，并提供了12个月的价格目标。平均目标为50.0美元，最高估计值为53.00美元，低估值为47.00美元。当前的平均价格从之前的平均目标价49.60美元上涨了0.81％，这是一个积极的转变。
Diving into Analyst Ratings: An In-Depth Exploration
深入分析师评级：深度探索
The analysis of...
对分析...
登录免费看全文
登录/注册
资讯热榜
更新时间